| Insurance Industry | Financials Sector | Mr. Andre Larente CEO | TSX-V Exchange | CA2524423068 ISIN |
| US Country | - Employees | - Last Dividend | 24 Apr 2019 Last Split | - IPO Date |
DIAGNOS Inc. is a dynamic company offering advanced software-based services with a primary focus on the healthcare sector. With a corporate footprint that extends beyond Canada to the United States, Colombia, Spain, Mexico, Saudi Arabia, and Costa Rica, DIAGNOS stands as a global entity dedicated to leveraging technology for health improvement. Founded in 1998 and with its headquarters in Brossard, Canada, the company has harnessed the power of data analysis and artificial intelligence to offer cutting-edge solutions. DIAGNOS Inc. is recognized for its innovative approach to medical diagnostics and consulting services, making significant contributions to the fields it operates in.
DIAGNOS Inc.'s flagship product, CARA, is a web-based software tool designed to revolutionize the way healthcare professionals detect diabetic retinopathy. This condition, a major complication of diabetes, can lead to significant visual impairment if not detected and treated in time. CARA supports eye care specialists by offering a platform for the visualization of both normal and pathological changes within the retina, facilitating early detection and management of this disease.
Beyond its software offerings, DIAGNOS extends its expertise through a range of consulting services concentrated in data analysis and the application of artificial intelligence. These services are tailored to help businesses and healthcare entities navigate the complexities of data interpretation, decision-making processes, and the implementation of AI-driven solutions. Through personalized consulting, DIAGNOS empowers its clients to achieve their strategic objectives by leveraging the power of advanced analytics and artificial intelligence.